‼️ Welcome to our 2nd Journal Club post 🏥🔪Today: Surgical technique for right-sided RPS ⁉️What does it take to achieve complete en bloc resection? Every step tests skill & precision. 🔗 pubmed.ncbi.nlm.nih.gov/30248168/

🔵 New month, new topic! In this case we walk through the management of a Left RPS, from preop to multivisceral resection. Why does it matter? Because in sarcomas, the first treatment makes the difference. 👇Have you ever faced such a case? Share your thoughts below! #Sarcoma

New from SICO Sarcoma Social & TARPSWG: Marco Fiore, MD, FACS, FEBSh on margins, Dirk Strauss on the left-sided approach, Gladdy Lab on histology-driven resection. 🧐Real surgeons, real strategy. Full video: youtube.com/@tarpswgeducat…

New Q&A session! All answers are evidence-based! Must-read papers: 🔗pubmed.ncbi.nlm.nih.gov/33740198/ 🔗pubmed.ncbi.nlm.nih.gov/40152715/ 🔗 pubmed.ncbi.nlm.nih.gov/31159625/

IEO Elisabetta Pennacchi Sara Coppola SICO

🚨 #STRASS trial & neoadjuvant RT in RPS: where do we stand? 📚 No ARFS benefit overall 📈 Signals in liposarcoma Your take on preop RT for low-grade LPS? 👉 Follow @SICOSarcoma for more. #SarcomaSurgery #RetroperitonealSarcoma CTOS TARPSWG Italian Sarcoma Group European Society of Surgical Oncology (ESSO)

Could neoadjuvant chemo reshape RPS treatment? #STRASS2 is testing if pre-op chemo improves outcomes in high-risk DDLPS & LMS. A game-changing randomized phase III trial in the making. 🧵👇 Like, Share and Comment! #SarcomaSurgery #SICOSarcomaSocial #ClinicalTrials

Neoadjuvant chemo in RPS? EORTC STRASS2 tests it in high-risk DDLPS & LMS. STREXIT 2 Project adds real-world insights from non-trial patients. Is this a shift in standard care? 🧠 Multidisciplinary judgment still key. #SarcomaSurgery #RPS #OncSurg #MedEducation

💥 Recurrent retroperitoneal sarcomas: rare, aggressive, and tough to treat. 🔪 Live surgery 🧠 Expert case discussions 📚 Guideline updates 🏥 Focus on referral centers 📍June 18 | Campus Bio-Medico, Rome 🌍 Also streaming online! #SarcomaSurgery #RetroperitonealSarcoma

For the first time, we’ve set benchmark values for surgery in primary retroperitoneal liposarcoma (WDLPS/DDLPS). 15 expert centres. 22 key metrics. A new standard for measuring surgical quality. Presented at #CTOS2024. Great collaborative effort from TARPSWG.

‼️ Pelvic Sarcoma A Solitary Fibrous Tumor managed at the Sarcoma Surgery Unit, ⁦Humanitas Milano⁩ (Dir. ⁦Ferdinando CM Cananzi⁩ ). #SarcomaSurgery #Teamwork #SICOSarcomaSocial #SurgicalOncology #RareTumors

🔎 Demicco Score in Solitary Fibrous Tumors (SFT): A practical, pathology-based tool to assess metastatic risk in primary SFTs. 3-variable (2012): Size, Mitoses, Age 4-variable (2017): + Necrosis 🧠 Do you use it in your practice? #Sarcoma #SFT #OncoPath

Il bando per la selezione di 3 felllow di chirurgia oncologica è fuori! Affrettatevi! fondazionesico.org/fellowship-in-…

More than 140 experts from around the world came together last week to work toward improving the standard of care for chordoma via upcoming updated consensus guidelines -- a remarkable effort. Grateful to Alessandro Gronchi, AO Spine & all who participated!

🎗 July is #Sarcoma Awareness Month! At the Italian Sarcoma Group, we’re committed every day to advancing research, improving care and standing by patients and families. Together, we fight rare cancers. 💛 #SarcomaAwareness #SarcomaStrong #ISG #RareButResilient

In Lyon for the WHO meeting to update the classification of soft tissue & bone sarcomas. A crucial step for diagnostics, research, and care in these rare tumors. Proud to contribute to this global effort. #Sarcoma #WHO #RareCancers #Pathology #Lyon2025 CTOS

Today is national #Leiomyosarcomaday and we stand with those who fight this rare disease. For more information on leiomyosarcoma, check out UCLA's research updates and education material here: ow.ly/v9Y350WoXuF